O-6-methylguanine DNA methyltransferase is a favorable biomarker with proliferation suppressive potential in Breast Cancer
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (21) , 6326-6336
Abstract
Background: The O-6-methylguanine-DNA methyltransferase (MGMT) is a highly effective enzyme capable of repairing DNA damage to maintain genomic stability. Until recently, reports on the expression and potential role of MGMT in breast cancer remain controversial. This study is intended to elucidate the prognostic significance and potential function of MGMT in breast cancer. Materials and methods: The immunohistochemistry assay and a series of public databases were utilized to determine the relevance between MGMT expression and clinicopathological characteristics, as well as survival outcomes in patients with breast cancer. The western blotting, qRT-PCR, proliferation, colony formation and transwell assays were used to investigate the potential function of MGMT in breast cancer cells. Results: The immunohistochemistry analysis and public cancer databases exploration demonstrated that MGMT expression was significantly related to estrogen receptor (ER) positivity in breast cancer. Positive expression of MGMT predicts a longer distant-free survival (DFS) and overall survival (OS) in patients with breast cancer, especially in ER-positive tumor. The mRNA level of MGMT was significantly associated with those of ESR1, GATA3 and FOXA1 in ER-positive breast tumor. Down-regulation of MGMT expression enhanced the proliferative and invasive capacities of breast cancer cells through PTEN/AKT pathway. Conclusions: MGMT is a favorable biomarker with proliferation suppressive potential in ER-positive breast cancer. Future study on targeted modulation of MGMT in the treatment of breast cancer is warranted.Keywords
This publication has 23 references indexed in Scilit:
- Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breastTumor Biology, 2015
- Breast cancer classification: linking molecular mechanisms to disease prognosisBriefings in Bioinformatics, 2014
- MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancersCancer Causes & Control, 2010
- Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis.2009
- O(6)-methylguanine-DNA methyl transferase gene expression and prognosis in breast carcinoma.International Journal of Oncology, 2002
- Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumoursBritish Journal of Cancer, 2002
- Expression and Prognostic Significance ofO 6-Methylguanine-DNA Methyltransferase in Hepatocellular, Gastric, and Breast CancersAnnals of Surgical Oncology, 2001
- Inactivation of the DNA repair gene O-6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia1999
- Expression of the O6-alkylguanine-DNA alkyltransferase gene is elevated in human breast tumor cells.1998
- O6-Methylguanine-DNA Methyltransferase in Normal and Malignant Tissue of the BreastCancer Investigation, 1994